Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Melanoma × Technetium-99 × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Blood Specimen Collection 12 Radiosurgery 7 Early Intervention, Educational 5 Surveys and Questionnaires 4 Standard of Care 4 Practice Guidelines as Topic 4 Methods 4 Educational Status 4 Surgical Procedures, Operative 3 Sentinel Lymph Node Biopsy 3 Nivolumab 3 Ipilimumab 3 Indocyanine Green 3 Immunotherapy 3 Cognitive Behavioral Therapy 3 Biopsy 3 pembrolizumab 2 montanide ISA 51 2 aldesleukin 2 X-Rays 2 Tomography, X-Ray Computed 2 Radiation 2 Magnetic Resonance Spectroscopy 2 Interleukin-2 2 In Situ Hybridization, Fluorescence 2 Immunohistochemistry 2 Immune Checkpoint Inhibitors 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Fluorescein 2 Diathermy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02057393 2017-07-06

SPY-SN

Milton S. Hershey Medical Center

Phase NA Completed

89 enrolled 3 charts

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡